Target Markets & Revenue Models
- Siiquent (Isolde): hospitals, big diagnostic labs
- Their model takes on a razor blade model approach where the consumables become a revenue-generating stream, and the machinese themselves are sold at basically cost.
- Teomik (Emanuel): research labs, universities
- Their model sells machines at a higher cost, as there’s less regulatory compliance to deal with in this target market. They have heavy emphasis on building credibility by offering Phd support/expertise.
Pros & Perils of Singular vs. Flexible Model
Pros:
- A flexible model could retain diverse use cases, ensuring that a company’s services can be tailored towards different segmented needs. This could be viewed as a model that has a co-dependent fallback plan if one revenue stream is not as strong.
- A singular model can help a company have more clarity in their strategy, and could potentially generate more revenue via clarity and a streamlined approach with sales. It would subsequently be easier to track and measure key performance metrics.
Perils:
- A flexible model can loses sight of the intended purpose of a merger, the company may still be viewed as two seperate companies within one company by the custoemr. This could also cause internal conflicts and rivalry that could negatively impede greater company values and revenue streams.
- A singular model can feel rigid, risking diverse customer alignment – alienating certain groups and challenge differences in market segmentation.
Recommendations: Merging the Process
I would scaffold the discussion by first surfacing the core tension around structure vs. adaptability and then mapping out the similarities and differences between the two departments. To ensure fairness, I’d give both leaders space to articulate their unit’s strengths and challenges, highlighting that their shared foundation leans on customer support, while their main divergence is in revenue logic. From there, I’d consider guiding them toward building a unified marketing front that leverages this shared strength. I’d then recommend piloting a hybrid model with two tailored packages: one for hospitals and one for research labs. This would help test how flexibility can coexist with a more streamlined go-to-market strategy. The ultimate goal would be to arrive at a unified brand and aligned value propositions that retain a diverse user base without thinning clarity. I think that these first pilot steps would balance both structure and adaptability while making the merger more purposeful than the current co-existing tensions.
